C1-esterase inhibitor human 500unit powder and solvent for solution for injection vials
NHS hospitals in England used £16,676,300 of indicative cost of C1-esterase inhibitor human 500unit powder and solvent for solution for injection vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is down 82.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. C1-esterase inhibitor human 500unit powder and solvent for solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using C1-esterase inhibitor human 500unit powder and solvent for solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Univ Hpl B/Ham Nhs Foundation Trust | £8,294,600 |
| Barts Health Nhs Trust | £1,079,370 |
| Aintree University Hospital Nhs Ft | £884,400 |
| Manchester University Nhs Ft | £772,510 |
| Frimley Health Nhs Foundation Trust | £719,580 |
| Sandwell And West Birmingham Hpls Trust | £531,310 |
| Leeds Teaching Hpls Nhs Trust | £460,960 |
| Cambridge Univ Hosp Nhs Foundation Trust | £423,440 |
| Western Sussex Hospitals Nhs Found Trust | £412,050 |
| North Bristol Nhs Trust | £334,330 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.